Dexcom (DXCM) Cash from Operations (2010 - 2026)

Dexcom (DXCM) has 17 years of Cash from Operations data on file, last reported at 525600000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations rose 185.96% year-over-year to 525600000.0 in Q1 2026; TTM through Mar 2026 was 1782500000.0, a 84.89% increase from a year earlier, with the FY2025 full-year figure at 1440700000.0, up 45.6% from the prior year.
• Cash from Operations for Q1 2026 stood at 525600000.0, up from 294000000.0 in the prior quarter.
• Over the last five years, Cash from Operations for DXCM reached as high as 659900000.0 in Q3 2025 and fell as low as 71000000.0 in Q1 2022.
• Historically, Cash from Operations has averaged 257282352.94 across 5 years, with a median of 209200000.0 in 2024.
• Across the five-year window, Cash from Operations dropped 25.89% in 2024 and surged 230.78% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 132500000.0 in 2022, then gained by 0.83% to 133600000.0 in 2023, then surged by 125.6% to 301400000.0 in 2024, then declined by 2.46% to 294000000.0 in 2025, then soared by 78.78% to 525600000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 525600000.0 in Q1 2026, 294000000.0 in Q4 2025, and 659900000.0 in Q3 2025.